사백산 추출물의 지방장벽 생성을 통한 Th2 분화 조절
Th2 Differentiation Control through Formation of Skin Fat Barrier of Sabaek-san extract
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives The purpose of this study is to confirm the regulate effect of T helper (Th) 2 differentiation that Sabaek-san extract may produce to improves skin lipid barrier damage. Methods Four-weeks-old NC/Nga mice were divided into four groups: control group (Ctrl, n=10), lipid barrier eliminated group (LBE, n=10), Dexamethasone treatment after lipid barrier elimination group (DXT, n=10), and Sabaek-san extract treatment group after lipid barrier elimination (SBT, n=10). Sabaek-san extract was administered for 3 d after removal of the skin fat barrier in SBT group. Then, we identified changes in external symptoms of the skin, factors affecting skin barrier such as potential of hydrogen (pH), filaggrin, transepidermal water loss (TEWL) and Th2 differentiation factors like Interleukin (IL)-4, Kallikrein Related Peptidase 7 (KLK7), and protease activated receptor 2 (PAR-2) through our immunohistochemistry. Results After lipid barrier elimination, the reduction of morphological skin inflammations was less in SBT group than in LBE and DXT group. Also, pH and TEWL were significantly decreased with SBT group. However, filaggrin was significantly increased in SBT group compared to LBE, DXT, and Ctrl group. All kinds of Th2 differentiation factors (IL-4, KLK7 and PAR-2) were also decreased in SBT compared to the LBE and DXT. Conclusions As a result of this study, SBT administration decreased pH, TEWL, and increased filaggrin, thus participating in recovering damaged skin barrier. Since Th2 differentiation factors were decreased as well, SBT’s regulatory effect in sequential immune reactions may be a possible explanation of how it enhances recovery of the damaged lipid barrier.
Abstract
Objectives The purpose of this study is to confirm the regulate effect of T helper (Th) 2 differentiation that Sabaek-san extract may produce to improves skin lipid barrier damage. Methods Four-weeks-old NC/Nga mice were divided into four groups: control group (Ctrl, n=10), lipid barrier eliminated group (LBE, n=10), Dexamethasone treatment after lipid barrier elimination group (DXT, n=10), and Sabaek-san extract treatment group after lipid barrier elimination (SBT, n=10). Sabaek-san extract was administered for 3 d after removal of the skin fat barrier in SBT group. Then, we identified changes in external symptoms of the skin, factors affecting skin barrier such as potential of hydrogen (pH), filaggrin, transepidermal water loss (TEWL) and Th2 differentiation factors like Interleukin (IL)-4, Kallikrein Related Peptidase 7 (KLK7), and protease activated receptor 2 (PAR-2) through our immunohistochemistry. Results After lipid barrier elimination, the reduction of morphological skin inflammations was less in SBT group than in LBE and DXT group. Also, pH and TEWL were significantly decreased with SBT group. However, filaggrin was significantly increased in SBT group compared to LBE, DXT, and Ctrl group. All kinds of Th2 differentiation factors (IL-4, KLK7 and PAR-2) were also decreased in SBT compared to the LBE and DXT. Conclusions As a result of this study, SBT administration decreased pH, TEWL, and increased filaggrin, thus participating in recovering damaged skin barrier. Since Th2 differentiation factors were decreased as well, SBT’s regulatory effect in sequential immune reactions may be a possible explanation of how it enhances recovery of the damaged lipid barrier.
참고문헌 (24)
- Kubo A, "Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases", J Clin Invest, 122(2), pp.440~447 (2012)
- 김현정, "아토피피부염과 피부 장벽 이상", Allergy Asthma & Respiratory Disease, 1(1), pp.20~28 (2013), 대한 소아알레르기 호흡기학회
- Rawlings AV, "Moisturization and skin barrier function", Dermatol Ther, 17(1), pp.43~48 (2004)
- Rippke F, "Stratum corneum pH in atopic dermatitis : impact on skin barrier function and colonization with Staphylococcus Aureus", Am J Clin Dermatol, 5, pp.217~223 (2004)
- Silverberg NB, "Inside out or outside in : does atopic dermatitis disrupt barrier function or does disruption of barrier function trigger atopic dermatitis?", Cutis, 96(6), pp.359~361 (2015)
- Yang G, "Skin barrier abnormalities and immune dysfunction in atopic dermatitis", Int J Mol Sci, 21(8), pp.2867~ (2020)
- Egawa G, "Multifactorial skin barrier deficiency and atopic dermatitis : essential topics to prevent the atopic march", J Allergy Clin Immunol, 138(2), pp.350~358 (2016)
- Drislane C, "The role of filaggrin in atopic dermatitis and allergic disease", Ann Allergy Asthma Immunol, 124(1), pp.36~43 (2020)
- Wu D, "Development and initial validation of a traditional Chinese medicine symptom-specific outcome measure : a Zheng-related atopic dermatitis symptom questionnaire(ZRADSQ)", Health Qual Life Outcomes, 11, pp.212~ (2013)
- Heo J, "Donguibogam", pp.470~ (1994), Namsandang
- 이동성, "사백산 물 추출물과 30% EtOH 추출물의 항염증 효과 비교연구", 약 학 회 지, 56(4), pp.240~247 (2012), 대한약학회
- 이해자, "瀉白散이 천식유발 백서에서 metrixmetalloproteinase-9(MMP-9)에 미치는 영향", 동의생리병리학회지, 18(6), pp.1694~1698 (2004), 한의병리학회
- 임광모, "알레르기성 질환에 대한 한의학적 접근", 동의생리병리학회지, 16(5), pp.1~839 (2002), 한의병리학회
- Seeliger S, "Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo", FASEB J, 17, pp.1871~1885 (2003)
- Egawa G, "Barrier dysfunction in the skin allergy", Allergol Int, 67(1), pp.3~11 (2018)
- Scharschmidt TC, "Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens", J Allergy Clin Immunol, 124, pp.496~506e1-6 (2009)
- Hönzke S, "Influence of Th2 cytokines on the cornified envelope, tight junction proteins, and ß-Defensins in filaggrin-deficient skin equivalents", J Invest Dermatol, 136(3), pp.631~639 (2016)
- Jung AR, "Douchi (fermented Glycine max Merr.) alleviates atopic dermatitis-like skin lesions in NC", Nga mice by regulation of PKC and IL-4, 2016, pp.16(1), 416~
- Kim HJ, "Understanding of skin barrier and integrated treatment on atopic dermatitis", Journal Skin Barrier Research, 12(1), pp.67~78 (2010)
- Demerjian M, "Acute modulations in permeability barrier function regulate epidermal cornification : role of caspase-14 and the protease-activated receptor type 2", Am J Pathol, 172(1), pp.86~97 (2008)
- Chen JQ, "Roles of kallikrein-related peptidase in epidermal barrier function and related skin diseases", Int J Dermatol Venereol, 2(3), pp.150~155 (2019)
- Soumelis V, "Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP", Nat Immunol, 3(7), pp.673~680 (2002)
- Boguniewicz M, "Atopic dermatitis: the updated practice parameter and beyond", Allergy Asthma Proc, 35(6), pp.429~434 (2014)
- Wollenberg A, "Proactive therapy of atopic eczema-an evidence-based concept with a behavioral background", J Dtsch Dermatol Ges, 7(2), pp.117~121 (2009)
